about
Cocos nucifera (L.) (Arecaceae): A phytochemical and pharmacological reviewOxidative stress and epilepsy: literature reviewAnimal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review.Preclinical Evidences for an Antimanic Effect of Carvedilol.Antidepressant effect of aminophylline after ethanol exposure.Melatonin: pharmacological aspects and clinical trends.Implications of efavirenz for neuropsychiatry: a review.Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms.Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness.Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress.IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity.Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression?Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole.Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders.HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum.Effects of early or late prenatal immune activation in mice on behavioral and neuroanatomical abnormalities relevant to schizophrenia in the adulthood.Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine.Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice.Screening for bipolar depression in family medicine practices: prevalence and clinical correlates.Different times of withdrawal from cocaine administration cause changes in muscarinic and dopaminergic receptors in rat premotor cortex.[Buspirone increases D2-like dopaminergic receptor density in rat corpus striatum].Effects of ethanol and haloperidol on plasma levels of hepatic enzymes, lipid profile, and apolipoprotein in rats.Alterations in monoamine levels after cocaine-induced status epilepticus and death in striatum and prefrontal cortex of mice.Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration.The relationship between religious coping, psychological distress and quality of life in hemodialysis patients.Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: possible involvement of GABAergic system and antioxidant activity.Gastroprotective activity of isopulegol on experimentally induced gastric lesions in mice: investigation of possible mechanisms of action.Coumarin effects on amino acid levels in mice prefrontal cortex and hippocampus.Angiotensin receptor blockers for bipolar disorder.Cocaine alters catalase activity in prefrontal cortex and striatum of mice.CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats.Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences.The translocator protein (18kDa) and its role in neuropsychiatric disorders.Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine.GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs.Two-hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: Study of sex differences and brain oxidative alterations.Brain antioxidant effect of mirtazapine and reversal of sedation by its combination with alpha-lipoic acid in a model of depression induced by corticosterone.Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
P50
Q26796276-DD5F7D21-6EC9-45A4-82ED-3CFFD29FBA2CQ26996304-EDECBE0C-BC79-4D39-B874-36EC7A58BAC9Q30445744-3E64DDCF-2384-4337-A5EB-040533F219CAQ35657017-461A8918-9024-4A4B-98AD-A0D321101BCDQ36743429-3CF26DC7-7C03-4CA3-BDEC-0B2C310EB0AAQ37779783-FEE06291-7860-42B7-B608-A7E0C59CD208Q37801927-3B573552-1A36-475B-BDDF-6980A5FD7D84Q38636993-20CC6B2B-53AC-47EF-B75E-9628E36EBFFFQ38981624-1A8E3343-C711-4B1C-B626-BC5C21C130CBQ39312488-2D9CC994-725F-4DCF-91D2-D67E1BB6023BQ39360365-580C4885-2181-4257-8138-0A0A521828BBQ39435527-2C5DE51A-A5E4-4438-B64E-B9CFF6BB846CQ39767106-51264E86-8A5E-4829-B95D-C30759C3255AQ40201273-8CBEDB11-AF26-4DC7-B949-25739F397049Q40336442-23408608-76CC-46D9-9E8F-7C000821B414Q40364821-99C63E3A-603F-45AB-8C3D-5CAF7C092B44Q42254252-8880F513-93D1-4EC4-A282-DBAD6CDA278BQ42987933-C5A84A5E-C1EF-483C-9885-8C36D0159927Q43501957-8D5C4143-251C-470A-9CFD-C612006C73B3Q43767705-2D419766-0077-478A-B65B-CA12B283F3C0Q43966795-C8364AA4-9A78-4D02-BDBD-D4098F6C524DQ44827367-2E074718-8C22-4548-A9C4-4EBE7D4664A7Q44906358-12EF2FC9-41F8-452B-9AA5-3F0986611C87Q45130984-D8E55F45-F67E-43CB-8E3A-35F4352AD7A3Q45136058-00A5AB05-410F-4DAE-9381-09AF833DD3A7Q45950262-509415F2-9EB3-4D11-BB1D-C87D5C305FFBQ45991150-6A128401-A152-4744-BB78-8A059B32D4FCQ46018130-43252A09-1081-4FBD-A316-B9DD9A4211A2Q46627201-E2BC6BD8-F91E-4F59-B335-2CE4B9920D4BQ46638974-0880C3C4-F243-4920-ABFC-E499D33C9AB6Q46829029-727B25D9-9028-4369-8680-12AE5EC8FFD6Q47354550-5EA9DBD8-A1EF-4A2D-8A70-91E5D8088235Q47382018-2D70E4D5-6D1B-46AC-9BB0-19E8AEDDDDE2Q47555401-BA517C22-FA6D-4811-A832-EDBB7E865F8CQ47622283-DAB3AB03-7635-4486-ABEB-4EF5577FF61DQ47670264-B5B285FE-7F72-4C6B-8C54-8249E28E95D7Q47685038-F9D51E6F-B180-4239-A75B-3D108FD20DBDQ47757902-70E25C11-93FE-4931-8F3C-D207FE2281ADQ47882410-6E62C226-E8B0-499C-B727-92BC77D13AC4Q47970067-471E2646-2677-4937-ABCD-90C2AB29FF85
P50
description
researcher ORCID ID = 0000-0001-8980-9970
@en
wetenschapper
@nl
name
Danielle Macedo
@ast
Danielle Macedo
@en
Danielle Macedo
@es
Danielle Macedo
@nl
type
label
Danielle Macedo
@ast
Danielle Macedo
@en
Danielle Macedo
@es
Danielle Macedo
@nl
prefLabel
Danielle Macedo
@ast
Danielle Macedo
@en
Danielle Macedo
@es
Danielle Macedo
@nl
P106
P1153
6603967181
P31
P496
0000-0001-8980-9970